X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (289) 289
male (209) 209
female (203) 203
clinical neurology (200) 200
middle aged (188) 188
peripheral vascular disease (155) 155
aged (149) 149
stroke (136) 136
adult (102) 102
risk factors (73) 73
aged, 80 and over (70) 70
treatment outcome (68) 68
stroke - drug therapy (61) 61
time factors (50) 50
prognosis (48) 48
thrombolysis (46) 46
follow-up studies (44) 44
adolescent (42) 42
neurosciences (41) 41
stroke - therapy (41) 41
acute ischemic-stroke (40) 40
fibrinolytic agents - therapeutic use (40) 40
thrombolytic therapy (40) 40
mortality (37) 37
neurology (35) 35
tissue plasminogen activator - therapeutic use (35) 35
brain ischemia - drug therapy (33) 33
ischemic stroke (33) 33
stroke - etiology (33) 33
stroke - complications (32) 32
stroke - mortality (32) 32
finland (31) 31
therapy (30) 30
alteplase (29) 29
brain ischemia - complications (29) 29
severity of illness index (29) 29
stroke - physiopathology (29) 29
cerebral infarction (28) 28
medicine, general & internal (28) 28
risk (28) 28
stroke - diagnosis (28) 28
stroke - epidemiology (28) 28
double-blind method (27) 27
magnetic resonance imaging (27) 27
retrospective studies (27) 27
tissue-plasminogen activator (27) 27
acute disease (26) 26
finland - epidemiology (25) 25
registries (25) 25
cohort studies (24) 24
further section (23) 23
age factors (22) 22
intravenous thrombolysis (22) 22
stroke - prevention & control (22) 22
original paper (21) 21
prevention (21) 21
trial (21) 21
brain (20) 20
care and treatment (20) 20
fibrinolytic agents - adverse effects (20) 20
ischemia (20) 20
outcome (20) 20
management (19) 19
odds ratio (19) 19
ecass (18) 18
fibrinolytic agents - administration & dosage (18) 18
multivariate analysis (18) 18
tomography, x-ray computed (18) 18
young adult (18) 18
brain ischemia - diagnosis (17) 17
double-blind (17) 17
randomized controlled trials as topic (17) 17
recurrence (17) 17
tissue plasminogen activator (17) 17
brain infarction (16) 16
brain ischemia - epidemiology (16) 16
prospective studies (16) 16
stroke - pathology (16) 16
tissue plasminogen activator - administration & dosage (16) 16
acute ischemic stroke (15) 15
association (15) 15
blood pressure (15) 15
brain - pathology (15) 15
disease (15) 15
drug therapy (15) 15
follow-up (15) 15
infarction (15) 15
medical and health sciences (15) 15
medicin och hälsovetenskap (15) 15
outcomes (15) 15
stroke patients (15) 15
thrombolytic therapy - methods (15) 15
clinical trials (14) 14
dementia (14) 14
europe (14) 14
ischemic-stroke (14) 14
prevalence (14) 14
research (14) 14
abridged index medicus (13) 13
animals (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2014, Volume 384, Issue 9958, pp. 1929 - 1935
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 375, Issue 9727, pp. 1695 - 1703
Journal Article
Neurology, ISSN 0028-3878, 05/2016, Volume 86, Issue 21, pp. 1981 - 1981
The idea, presented here, that emergency medical services transporting acute stroke patients should bypass hospitals without stroke units (SUs) and experience... 
THROMBOLYSIS | CLINICAL NEUROLOGY
Journal Article
Lancet neurology, ISSN 1474-4422, 2009, Volume 8, Issue 2, pp. 141 - 150
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2016, Volume 15, Issue 9, pp. 925 - 933
Journal Article
Lancet neurology, ISSN 1474-4422, 2015, Volume 14, Issue 6, pp. 575 - 584
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 359, Issue 13, pp. 1317 - 1329
Journal Article
Lancet neurology, ISSN 1474-4422, 2008, Volume 7, Issue 10, pp. 875 - 884
Summary Background The treatment of ischaemic stroke with neuroprotective drugs has been unsuccessful, and whether these compounds can be used to reduce... 
Neurology | SYSTOLIC HYPERTENSION | MINI-MENTAL-STATE | VASCULAR DEMENTIA | RATS | CANDESARTAN | BASE-LINE DATA | COMBINATION | CEREBRAL-ISCHEMIA | UMCG Approved | CEREBROVASCULAR-DISEASE | ELDERLY SCOPE | DEMENTIA | PRETREATMENT | RAMIPRIL | PROGNOSIS | HYPERTENSION | CLINICAL NEUROLOGY | DECLINE | Benzoates - therapeutic use | Follow-Up Studies | Ticlopidine - therapeutic use | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Male | Secondary Prevention | Stroke - physiopathology | Drug Delivery Systems | Mental Status Schedule | Female | Aspirin - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Disability Evaluation | Severity of Illness Index | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | International Cooperation | Cognition - drug effects | Ticlopidine - analogs & derivatives | Aged | Prevention | Stroke (Disease) | Medical colleges | Care and treatment | Ischemia | Analysis | Dipyridamole | Clinical trials | Drugs | Neuroprotection | Angiotensin II receptors | Aspirin | Stroke | Motivation | Cognitive ability | Dementia disorders | Clopidogrel | Age | Recurrence | Benzimidazoles | Neurons and Cognition | Cognition | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Benzoates | Ticlopidine | Platelet Aggregation Inhibitors | Santé publique et épidémiologie
Journal Article